Global Out-Licensing Considerations for Manufacturers

The biopharmaceutical ecosystem is facing heightened uncertainty, driven by funding constraints, regulatory shifts, and policy reforms—including pricing pressures and the potential expansion of international reference pricing. These dynamics are reshaping dealmaking and raising critical questions for companies pursuing global out‑licensing strategies.

Join experts from Covington for a timely discussion on how these trends are influencing licensing decisions, with insights on:

• Structuring Out‑Licensing Agreements and Territory Splits – strategic and practical considerations
• Policy Impacts on Licensing – Key developments in the U.S. and EU
• Executing Near‑Term Deals – practical guidance in an evolving market

++++++++++++++++++++++ 

This program is accredited for CLE in CA and NY (for both newly admitted and experienced attorneys). Credit will be applied as requested but cannot be guaranteed for VA or WA. The following jurisdictions may accept reciprocal credit: AZ, AR, CT, NJ, and HI. A general certificate of attendance and necessary materials will be provided for all other jurisdictions to support self-application. To receive CLE credit, attendees must complete the CLE Attendance Verification Form within 5 business days of the program. This form must be submitted after the program using the verification code shared during the session. 

++++++++++++++++++++++